FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.Kyle Grillot | Bloomberg | Getty ...
Tag: Health care industry
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn't ...
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human ...
How the ‘K-shaped’ economy is showing up at two big U.S. gyms
Two of the largest U.S. gym operators delivered the same headline in their latest earnings reports: strong growth.But beneath the ...
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and ...
White House launches direct-to-consumer drug site TrumpRx. Here’s what to know
President Donald Trump makes an announcement from the Oval Office at the White House in Washington, Nov. 6, 2025.Jonathan Ernst ...
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for ...
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg ...
OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion
A startup widely known as "ChatGPT for doctors" raised a new funding round that values the company at $12 billion. ...
Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg ...
